Skip to main content
Journal of Education and Health Promotion logoLink to Journal of Education and Health Promotion
. 2023 Apr 28;12:130. doi: 10.4103/jehp.jehp_721_22

A data set for the design and implementation of the upper limb disability registry

Khadijeh Moulaei 1,*, Abbas Sheikhtaheri 2,*, Ali A Haghdoost 3, Mansour S Nezhadd 4, Kambiz Bahaadinbeigy 1,
PMCID: PMC10312779  PMID: 37397108

Abstract

BACKGROUND:

If the data elements needed for patient registries are not identified, designing and implementing them can be very challenging. Identifying and introducing a Data Set (DS) can help solve this challenge. The aim of this study was to identify and present a DS for the design and implementation of the upper limb disability registry.

MATERIALS AND METHODS:

This cross-sectional study was conducted in two phases. In the first phase, to identify the administrative and clinical data elements required for registry, a comprehensive study was conducted in PubMed, Web of Science, and Scopus databases. Then, the necessary data elements were extracted from the studies and a questionnaire was designed based on them. In the second phase, in order to confirm the DS, the questionnaire was distributed to 20 orthopedic, physical medicine and rehabilitation physicians and physiotherapists during a two-round Delphi. In order to analyze the data, the frequency and mean score of each data element were calculated. Data elements that received an agreement more than 75% in the first or two-round Delphi were considered for the final DS.

RESULTS:

A total of 81 data elements in five categories of “demographic data”, “clinical presentation”, “past medical history”, “psychological issues”, and “pharmacological and non-pharmacological treatments” were extracted from the studies. Finally, 78 data elements were approved by experts as essential data elements for designing a patient registry for upper limb disabilities.

CONCLUSION:

In this study, the data elements necessary for the design and implementation of the upper limb disability registry were suggested. This DS can help registry designers and health data administrators know what data needs to be included in the registry system in order to have a successful design and implementation. Moreover, this standardized DS can be effective for integrating and improving the information management of people with upper limb disabilities and used to accurately gather the upper limb disabilities data for research and policymaking purposes.

Keywords: Data set, disabilities, registries, upper extremity

Introduction

Upper limb conditions are very common in the general population and are often associated with disability and pain. Upper limb disabilities have a greater impact on disability and limitations in normal activities than other parts of the body.[1] Also, people with upper limb disabilities can experience challenges such as paralysis, loss of sensation, pain, and spasticity in the hands, arms, and shoulders. Therefore, treatment of these patients is a basic need.[2] One way to help better treat patients with upper limb disabilities is for therapists to have access to their data and information.[3]

Registries can be described as a longitudinal, systematic, and accurate collection of real-world data that describes health status and medical interventions in a given population of individuals. Registries allow the collection of real-world data on the clinical course of diseases and their impact on patients and healthcare providers.[4] Bae et al.,[5] by examining the registry of congenital malformations and disorders of the upper extremities, showed that the data recorded in these registries help to further investigate the impact of congenital malformations of the upper extremities on society. In another study, Bae et al.,[6] noted that through continuous recording and longitudinal follow-up, registries can increase understanding of upper limb functions and the psychosocial aspects of children's health. Also, these powerful tools can be used to understand variations in treatment and outcomes, study the course of the disease, understand changes in treatment and outcomes, examine factors affecting prognosis and quality of life, and describe care patterns including: care appropriateness and inequalities in providing medical services, evaluating effectiveness, monitoring safety and injury, and assessing the quality of care.[7]

Properly designed and executed disease registries can provide a real-world view of clinical practice, patient outcomes, safety, and comparative effectiveness.[7] In order for us to successfully design a registry to collect accurate data, we must first identify its Data Set (DS). Using DS as a standard tool for collecting integrated, accurate, and standard data is very helpful.[8] DS is used in a disease registry to access reliable and comparable information about the number of patients, treatment methods and outcomes of the provided health services relating to a specific disease.[9] DSs can also be used as a tool to record the most relevant and up-to-date health facts and provide timely decision-making for administrators by supplying a minimum level of variables related to the health condition of the individual including clinical, demographic, financial data.[10] While there is a growing interest in different countries to adopt a DS, no research has been undertaken so far in order to identify a DS for the design and implementation of the upper limb disability registry. To our knowledge, this study is the first study in which a DS for the design and implementation of the upper limb disability registry has been identified and presented. Only two studies by Bae et al.[5,6] were related to upper limb disability registries. These two studies also used registries to examine the effect of using Oberg-Manske-Tonkin (OMT) on recording congenital upper limb differences and assessing the functional, emotional, and social effects of congenital hand differences in children, respectively; however, no DSs were introduced and presented in these two studies. Therefore, the purpose of this study was to provide a DS for the design and implementation of an upper limb disability registry.

Materials and Methods

Study design and setting

This cross-sectional study was conducted in the two phases: Identify the data elements needed to design an upper limb disability registry and final approval of data elements using a Delphi study. These two phases are described in Figure 1.

Figure 1.

Figure 1

Study diagram

Phase 1: Identify the data elements needed to design an upper limb disability registry

Search strategy

At this phase, we first reviewed the literature to identify the necessary data elements related to upper limb disability and registries on November 11, 2020, from three databases: PubMed, Web of Science, and Scopus. To retrieve related articles, we searched title and abstract of articles using following keywords and search strategy: ((upper extremity disability OR upper limb disability) AND (registries OR registry OR clinical registry OR patient registry OR disease registry population OR Register OR Minimum Data Set OR MDS OR data Set OR database)).

Inclusion and exclusion criteria

Inclusion criteria included publication of the article in English, access to the full text of the articles, mention of data elements and clinical and managerial parameters related to the upper limb disabilities in the articles. Exclusion criteria also included articles addressing other aspects of upper limb disabilities and failure to provide clear information on the clinical and managerial parameters of upper limb disabilities. Books and book chapters, letters to the editor, and abstracts of the conferences were excluded.

Selection and classification of articles

A total of 779 articles were extracted from the three databases. After removing duplicate articles (n = 174), the title and abstract of the articles were studied by one of the researchers (KhM and KB). Then, according to the inclusion and exclusion criteria, articles were included in the study. The articles included in the study were reviewed and approved by three researchers (KB, MSH, and ASh). Then, to extract the required data elements, the full text of these articles were studied (KhM and ASh). Finally, the extracted data elements were reviewed and finalized by three other researchers (ASh, KB, and AAH). At this stage, data collection was done with a data extraction form. This form included fields such as data element and reference.

Phase 2: Final approval of data elements using a Delphi study

Study participants and sampling

The study population included Orthopedists and physical medicine and rehabilitation specialists and Physiotherapists working in educational and medical centers affiliated to Kerman University of Medical Sciences (KUMS). Since in most Delphi studies the number of experts has been usually 15 to 20, 20 specialists and subspecialists in physical medicine and rehabilitation, orthopedists and physiotherapists were selected to participate in the study.[11] The following inclusion criteria were used to select participants:

  • Employment of participants in educational and medical centers affiliated to KUMS

  • Have a history of activity in the treatment or rehabilitation of upper limb disabilities for more than five years.

Data collection tool and technique

At this phase, the data collection tool was a questionnaire. This questionnaire was designed using the data elements identified in the previous stage. The designed questionnaire consisted of two parts: the first part included demographic information of experts and the second part included 98 questions related to data elements necessary to design the DS. These data elements were divided into five main categories: “demographic data”, “clinical presentation”, “past medical history”, “psychological issues” and “pharmacological and non-pharmacological treatments”. Also, to identify other data elements that were not listed in the questionnaire, an open-ended question was added at the end of the questionnaire.

A number between one and five was considered for scoring each data element. The face and content validity of the questionnaire was confirmed according to the opinions of medical informatics experts (two people), physical medicine and rehabilitation (one person), physiotherapist (one person), and a health information management expert. Based on the comments received, some synonymous and unrelated data elements were removed from the questionnaire and finally 80 data elements were approved for the questionnaire (18 data elements were removed).

The questionnaire was designed electronically. In the first round of Delphi, a questionnaire link was sent to the experts on October 10, 2021. By October 30, all questionnaires were completed. After collecting the questionnaires, the data were entered in SPSS 23.0, and then the frequency and mean score of each data element were calculated and analyzed. In order to decide on each data element in the first round of Delphi, an agreement level was considered. Data elements with an agreement of less than 50% (mean less than 2.5) were excluded, data elements with an agreement of 50 to 75% (mean 2.5 to 3.75) were re-assessed in the second round of Delphi, and data elements with an agreement of more than 75% (mean more than 3.75) (no need to re-measure in the second round of Delphi) were considered as the final data elements.[12,13] The second round Delphi questionnaire included data elements with an agreement of 50 to 75% (mean 2.5 to 3.75). One month after the first round of Delphi, that is, on November 10, 2021 the link to this questionnaire was sent to the same first-round Delphi participants. In the second round, after analyzing the data elements, only data elements that scored more than 75% (mean more than 3.75) were considered as data elements needed to design the registry of upper limb disabilities, data elements with an agreement below 50 were excluded, and data elements with an agreement of 50 to 75% were included into three-round Delphi. The process of including data elements into different Delphi rounds was repeated until all data elements agreement less than 50% or more than 75%.[12]

Ethical considerations

The protocol of this study was approved by research ethical committee of Kerman University of Medical Sciences (IR.KMU.REC.1400.606). The physiotherapists and physician's participation in the first and second round of Delphi was also completely voluntarily, and they had the chance to leave the study at any time without any consequences.

Results

Phase 1: To identify the data elements needed to design an upper limb disability registry

In accordance with the inclusion and exclusion criteria and after reviewing the articles, finally 64 articles were included in the study.[14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76] Eighty-two data elements extracted from these articles.

Phase 2: Final approval of data elements using a Delphi study

The frequency of men (80%) was higher than women. Most participants (45%) were between 35 and 44 years old. Most of these participants had between 5 and 15 years of service [Table 1].

Table 1.

Participants’ demographics

Variables Frequency (%)
Sex
 Male 16 (80)
 Female 4 (20)
Age
 25-34 7 (35)
 35-44 9 (45)
 45-54 3 (15.0)
 >54 1 (5)
Education level
 Bachelor 3 (15)
 Master 4 (20)
 PhD 3 (15)
 Specialists 8 (40)
 Subspecialists 2 (10)
Type of medical specialties
 Physiotherapists 10 (50)
 Orthopedists 6 (30)
 Physical medicine and rehabilitation 4 (20)
Years of service (Year)
 5-15 9 (45)
 16-25 7 (35)
 >25 4 (20)

The 82 data elements were divided into five categories: demographic data, past medical history, current history, psychological issues, and pharmacological and non-pharmacological treatments [Table 2]. Of the 81 data elements identified, 78 data elements were finally validated by experts as essential data elements for designing and presenting the upper limb disability registry DS in two Delphi rounds. In the first round of Delphi, the two data elements “father's name” and “income” were excluded from the study (agreement of less than 50%). Also, in the second round of Delphi, the “phone number” data element was removed.

Table 2.

Clinical and administrative data primary groups for a minimum data set for UP

Category The number of data elements First round of Delphi Second round of Delphi The final number of data elements


<50% 50-75% ≥75% <50% 50-75% ≥75%
Demographic information 15 2 6 7 1 0 5 12
Past medical history 35 0 0 34 0 0 0 35
Clinical presentation 19 0 0 19 0 0 0 19
Psychological issues 5 0 0 5 0 0 0 5
Pharmacological and non-pharmacological treatments 7 0 0 7 0 0 0 7

As shown in Table 2, out of five categories, four categories of past medical history, clinical presentation, psychological issues, and pharmacological and non-pharmacological treatments, all their data elements were approved in the first round of Delphi.

Six data elements: “date of birth” (3.45 (±1.27)), “marital status” (3.20 (±1.24)), “education level” (3.60 (1.04)), “place of residence” (3.30 (±0.92)), “phone number” (3.60 (±1.23)) and “body mass index” (3.70 (±1.12)) included the second round of Delphi with an agreement of 50 to 75. All accepted or rejected data elements in the first and second rounds of Delphi with standard deviation and mean score are shown in Tables 3 and 4.

Table 3.

Accepted or rejected data elements in the first round of Delphi

Category Data elements Mean (SD) Decision
Demographic data Record number 4.20 (0.83)
National code 4.30 (0.86)
First name 4.05 (1.05)
Last name 4.05 (1.05)
Date of birth 3.45 (1.27) *
Father name 2.00 (1.07) ×
Gender 3.85 (0.93)
Age 4.25 (0.91)
Income 2.35 (1.04) ×
Marital status (Single, married, widowed, divorced) 3.20 (1.24) *
Literacy level (Illiterate, elementary, cycle, diploma, master diploma, bachelor, master, PhD) 3.60 (1.04) *
Occupation (Unemployed, housewife, freelancer, retiree, government employee) 3.79 (1.07)
Place of residence (City, village) 3.30 (0.92) *
Phone number 3.60 (1.23) *
Body mass index (BMI) 3.70 (1.12) *
Past medical history History of underlying diseases (Heart disease, stroke, hypertension, MS, Parkinson’s, etc.) 4.30 (0.97)
Consumption of drugs, cigarettes and alcohol 4.00 (0.97)
Hospitalization history 3.95 (0.79)
Duration of hospital stay 3.94 (0.78)
History of surgery on the upper limb 4.45 (0.66)
Anatomical location of the surgery 4.45 (0.68)
Laterality of hand surgery (Left, right hand, or both) 4.55 (0.60)
Cause of upper limb disability (Illness, birth defects, accident, burn, etc.) 4.45 (0.68)
Hand with a disability (Right or left hand or both) 4.25 (0.71)
Upper limb defect level (Shoulder disarticulation, below the elbow, above the elbow, below the wrist, above the wrist) 4.50 (0.51)
Duration of disability and/or upper limb defect 4.15 (0.87)
Abnormalities or deformities in the upper limbs (Polydactyly, syndactyly, reduction defects, clubhand malformations, and syndromes with upper limb anomalies) 4.55 (0.60)
Existence of a mass in the upper limb and its anatomical location 4.15 (0.81)
Motor deficits history 4.35 (0.48)
Amputation in the upper limb 4.35 (0.58)
Amputation level (One finger or more, unilateral, Bilateral, other parts of upper limbs) 4.40 (0.50)
History of hemiparesis 4.20 (0.76)
Hand involved in hemiparesis (Right or left hand or both) 4.25 (0.85)
History of hemiplegia 4.45 (0.60)
Hand involved in hemiplegia (Right or left hand or both) 4.65 (0.48)
History of Shoulder arthroplasty 4.20 (0.89)
Shoulder arthroplasty (Right or left hand, both hands) 4.20 (0.89)
Rotator cuff syndrome 4.10 (0.96)
Hand involved in rotator cuff syndrome (Right or left hand or both) 3.80 (0.89)
Carpal tunnel syndrome (CTS) 4.00 (0.64)
Hand involved in carpal tunnel syndrome (Right or left hand or both) 3.85 (0.74)
History of muscular and neurological diseases (such as Decoron’s disease, Epicondilytis, ulnar nerve compression, etc) 4.15 (0.81)
Osteoarthritis of the upper limbs (joints, elbows, wrists and fingers, etc.) 4.40 (0.82)
Upper limb spasticity 4.30 (0.92)
Degenerative arthritis/decreased joint range of motion 4.30 (0.73)
Obstetric brachial plexus 4.40 (0.75)
Upper limb arterial injury 4.35 (0.74)
List of medications (such as analgesics, anticoagulants with vitamin K antagonists, etc.) 3.95 (0.88)
Dominant hand (Right/left/ambidextrous) 3.85 (0.98)
Clinical presentation Existence of closed wounds in the upper limb 4.10 (0.64)
Existence of open wounds in the upper limb 4.20 (0.52)
Musculoskeletal pain (Sudden, intermittent, chronic, at rest, at night, in moving, during the care process, etc.) 4.25 (0.85)
Intensity of musculoskeletal pain (Painless, mild pain, moderate pain, severe pain) based on VAS scale 4.25 (0.63)
Anatomical location of pain (Shoulder, shoulder, wrist, elbow, etc.) and number of pain points 4.10 (0.91)
Duration of pain 4.15 (0.81)
Numbness and tingling in the upper limb along with its anatomical location 4.10 (0.64)
Muscle stiffness 4.30 (0.57)
Hand and finger strength (based on Dynamometry scale) 4.15 (0.48)
Inflammation and swelling of the joints 4.15 (0.58)
Tendinosis/impingement 4.30 (0.65)
Vibration in the upper limb 4.10 (1.07)
Contraction of the upper limb joints 4.10 (0.78)
Extent of independence in daily activities (Complete dependence on others, severe dependence on others, moderate dependence, mild and independent dependence or no need for help) 4.30 (0.73)
Range of motion of different parts of the upper limb (based on MMT/ROM) 4.25 (0.78)
Bending of the fingers, elbows and other parts of the upper limbs 4.300.65)
Existence of infection in the upper limb and soft tissue necrosis 4.30 (0.73)
Injuries due to fractures, dislocations, sprains/strains, tears, contusions, nerve damage, joint disorders, tendon injuries, flexors in the upper limb 4.30 (0.65)
Weakness in the upper limb (based on Dynamometry scale) 4.35 (0.58)
Psychological issues Depression related to upper limb disability 3.85 (0.67)
Anxiety and distress related to upper limb disability 3.80 (0.69)
Need for social support 3.90 (0.85)
History of suicide attempt due to a defect in the limb 3.95 (0.88)
Social support at work 3.90 (0.91)
Pharmacological and non-pharmacological treatments Brunnstrom Movement Therapy 3.80 (1.28)
Stage and number of rehabilitation sessions performed 3.85 (1.2)
Upper limb orthosis 3.90 (1.16)
Prescribing of Medication (name of medications, medication ID, type of medications, value, dose, and type of prescription) 3.80 (0.69)
Prescribe therapeutic or rehabilitation exercises 4.10 (718)
Botulinum toxin prescription 3.85 (988)
Prescribe muscle function measurement with EMG 3.95 (1.05)

*Note: Assessment in second-round Delphi, ×: Final exclusion and √: Final Acceptance

Table 4.

Data elements examined in the second round of Delphi

Category Data elements Mean (SD) Decision
Demographic data Date of birth 4.25 (0.91)
Marital status (Single, married, widowed, divorced) 4.02 (1.03)
Literacy level (Illiterate, elementary, cycle, diploma, master diploma, bachelor, master, PhD) 4.05 (1.05)
Occupation (Unemployed, housewife, freelancer, retiree, government employee) 3.95 (0.88)
Phone number 2.20 (1.11) ×
Body mass index (BMI) 4.45 (0.68)

*Note: ×: Final exclusion and √: Final Acceptance[13]

As shown in Table 4, five data elements: “date of birth” (4.25 (±0.91)), “marital status” (4.02 (±1.03)), “literacy level” (4.05 (±1.05)), “occupation” (3.95 (±0.88)) and “Body mass index (BMI)” (4.45 (±0.68)) were confirmed in the second round. “Phone number” (2.20 (±1.11)) was excluded during this round.

Discussion

In this study, a DS was designed for a patient registry of upper limb disabilities. 82 data elements were identified in five categories: demographic data, past medical history, clinical presentation, psychological issues, and pharmacological and non-pharmacological treatments. Of the 82 data elements identified, 77 data elements were eventually approved by experts as the final upper limb disability registry DS.

Record number, national code, first name, last name, year of birth, gender, age, marital status, literacy level, occupation, place of residence, and BMI were data elements confirmed in our study in the category of demographic data. Also in the category of past medical history are data elements such as history of surgery on the upper limb and its anatomical location, upper limb spasticity, contraction of the upper limb joints, cause of upper limb disability, duration of the disability or defect, abnormalities or deformities in the upper limbs, spasticity, and amputation were approved. Biering-Sørensen et al.[77] designed a dataset for the International Spinal Cord Injury (SCI) upper limb. Their DS includes data elements such as time since the initial spinal cord lesion, hand-upper limb function, shoulder function classification, SCI-related complications affecting upper limb function like pain, use of assistive devices, spasms, contractures and edema, performed upper limb/hand reconstructive surgery, upper limb/hand reconstructive surgery. Their DS also includes data elements such as date of birth, duration of the injury, gender, the cause of SCI, and neurological status. Biering-Sørensen et al.[77] stated that this international upper extremity SCI DS facilitates the collection of standard data and the continuous reporting of upper extremity outcomes, enables comparison of outcomes, and facilitates SCI research.

”International Spinal Cord Injury Upper Extremity Basic Data Set”[77] and “International Spinal Cord Injury Core Data Set”,[78] also emphasize demographic data elements such as date of birth, age, and gender. Studies have shown that demographic data are needed to obtain various information about health outcomes and vital events such as fertility, morbidity, mortality, and migration, and these data elements need to be considered in the design of registries.[79] For example, information about the age of study participants is very important for interpretation of results and comparing results across studies. Gathering date of birth information is the most accurate way to gather and store this information, as it allows easy calculation of age at injury as well as age at any future point in time when data might be collected.[78] Also, since the gender of a study population is important and most of the health consequences relate to it, this data element should always be considered in registries.[78] Richesson et al.[80] noted that important data that should be included in the registries for rare diseases and disabilities include genetic factors to establish genotype-phenotype correlations, family history, concomitant medications, and medical or surgical interventions. Lucyk et al.,[81] also believed that administrative data is used to monitor population, geographical change, population health, and healthcare planning.

But the clinical data collected by clinical staff relies on diagnosis and treatment and is used to help conduct research, health planning and policymaking.[82] These data are also essential for providing quality healthcare, improving healthcare management, reducing healthcare costs, population health management, conducting quality clinical research, and meeting the needs of funders and healthcare managers.[83,84] Considering the clinical data elements related to the patient's medical history such as surgeries, etiology of injury, associated injuries, signs and symptoms, date and place of discharge can accurately record patients’ information and thus improve treatment processes for them.[78] For example, information on whether there is a spinal fracture and/or dislocation associated with SCI is important because treatment methods, length of stay, and treatment outcomes are usually related to the presence or absence of a spinal cord injury.[78]

DeVivo et al.,[78] also designed and presented an international DS for international spinal cord injury. This dataset contains data elements such as demographic features, dates of admission and discharge from first acute and rehabilitation care, reason of injury, place of discharge, existence of vertebral injuries and associated injuries, occurrence of spinal surgery, and measurements of neurological and was ventilator state.[78] Hughes et al.[85] reported the agreement reached on assessment protocols and outcome measures for evaluation of the upper limb in neuro-rehabilitation using technology. In this study, data elements (technology-generated data (e.g., kinematic, kinetic and activity measurements), movement quality, EMG, neuro-physiological measures and neuropsychological measurements and other non-motor areas such as attention, neglect, conflict and reaction time and pain agreement was obtained.

In another study,[86] an international spinal cord injury musculoskeletal basic DS was designed.

In the “International Spinal Cord Injury Pain Basic Data Set”, there are data elements such as: any pain during the last seven days, number of various pain problems, description of the three worst pain difficulties, location of pain, mean pain intensity in the last week, types of pain, date of onset, number of days with pain in the last 7, time period of pain, and pain interference.[87] Widerström-Noga et al.[87] believed that the pain affects physical, social, and emotional functioning and even sleep, and that considering this data element in the DS is an essential data element. Therefore, it is necessary to include the parameters of pain intensity grading, pain classification and time pattern questions for each specific pain in the DS.[87] None of the datasets examined in these studies[77,78,85,86,87] focused specifically on the upper extremities. Also, what we observed in these studies, unlike the present study, is that none of these studies focused on psychological issues and patients’ pharmacological and non-pharmacological treatments. However, it is important to pay attention to the type of treatment and psychological issues among people with upper limb disabilities, especially when the upper limb is disabled or amputated. Davidson et al.[88] described disability and amputation as a catastrophe for adults and their families, which can be associated with low self-esteem, anxiety and depression, impaired quality of life, and limited participation in society. Therefore, considering these types of data elements for registration can help to understand changes in treatment, upper limb function, psychosocial aspects of patients’ health, and management decisions.[6,7]

According to the findings of this study and other studies and pharmacological and non-pharmacological treatments such as rehabilitation[89] and the need for Brunnstrom therapy,[90] upper limb orthotics,[91,92] medication,[93,94] botulinum toxin treatment[95,96] and muscle function measurement with EMG[97] are the basic needs of these patients and should be included in the registry DS. Stewart et al.[98] argued that non-pharmacological approaches to treating post-stroke disabilities such as upper extremity disabilities should always be considered, especially for older patients. Because non-pharmacological interventions, such as rehabilitation and occupational therapy techniques, improve the activities of daily living among stroke survivors, they should be considered as essential data elements in the design of registry systems and information about them should be recorded in these systems.[98] In addition to non-pharmacological treatments, data elements related to pharmacological treatments should also be considered in the minimum data set.[99] In our study, these data elements were also included. By considering these data elements in a registry DS, we can increase the effectiveness and quality of care programs, provide an approach to improve the quality of care, and help managers and policymakers make timely and correct decisions.

Limitation and recommendation

This study had some limitations. To our knowledge, no DS has been provided for patients with upper extremity disabilities. Therefore, other studies related to upper limb disabilities were used to gain basic knowledge about DS presented in this study. It is suggested that similar studies be performed in accordance with the clinical needs and facilities of each country. We also used the opinions of experts in a city (Kerman) to confirm the data elements, it is suggested that future studies be conducted on a larger scale. In this study, we also did not use this DS in practice and in the real world. It is suggested that an upper limb registry be designed and implemented based on this DS to evaluate its applicability.

Conclusion

In this study, a DS was designed and presented to design and implement a registry for upper limb disabilities. Using this DS, it is possible to help registry designers and health data managers to know what information needs to be included in the system when designing these systems in order to have a successful design and implementation. Therefore, after creating a registry based on a DS, a reliable source of information can be provided for more detailed research and management decisions.

Financial support and sponsorship

Source(s) of support in the form of grants, equipment, drugs, or all of these: For this study, the code of ethics with the number IR.KMU.REC.1400.606 was obtained from the ethical committee of Kerman University of Medical Sciences. All methods of the present study were performed following the relevant guidelines and regulations of the ethical committee of Kerman University of Medical Sciences. The funder had no role in study design, data collection, and analysis.

Conflicts of interest

There are no conflicts of interest.

Acknowledgments

The authors would like to thank all experts who participated in this study.

References

  • 1.Shafiee E, Farzad M, Karbalaei M. A systematic review of self-reported outcome measures assessing disability following hand and upper extremity conditions in Persian population. Arch Bone Jt Surg. 2021;9:141–51. doi: 10.22038/abjs.2020.48859.2423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Poltawski L, Allison R, Briscoe S, Freeman J, Kilbride C, Neal D, et al. Assessing the impact of upper limb disability following stroke: A qualitative enquiry using internet-based personal accounts of stroke survivors. Disabil Rehabil. 2016;38:945–51. doi: 10.3109/09638288.2015.1068383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Sinnott K, Dunn J, Rothwell A, Hall A, Post MW. The development of the NZ-based international upper limb surgery registry. Spinal Cord. 2014;52:611–5. doi: 10.1038/sc.2014.57. [DOI] [PubMed] [Google Scholar]
  • 4.Culver DA, Behr J, Belperio JA, Corte TJ, de Andrade JA, Flaherty KR, et al. Patient registries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2019;200:160–7. doi: 10.1164/rccm.201902-0431CI. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bae DS, Canizares MF, Miller PE, Roberts S, Vuillermin C, Wall LB, et al. Intraobserver and interobserver reliability of the Oberg-Manske-Tonkin (OMT) classification: Establishing a registry on congenital upper limb differences. J Pediatr Orthop. 2018;38:69–74. doi: 10.1097/BPO.0000000000000732. [DOI] [PubMed] [Google Scholar]
  • 6.Bae DS, Canizares MF, Miller PE, Waters PM, Goldfarb CA. Functional impact of congenital hand differences: Early results from the congenital upper limb differences (CoULD) registry. J Hand Surg Am. 2018;43:321–30. doi: 10.1016/j.jhsa.2017.10.006. [DOI] [PubMed] [Google Scholar]
  • 7.Gliklich RE, Leavy MB, Dreyer NA, editors . 4th ed. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014. Registries for Evaluating Patient Outcomes: A User's Guide [Internet] Sep. Report No: 19 (20)-EHC020. PMID: 33001604. [PubMed] [Google Scholar]
  • 8.Ahmadi M, Mirbagheri E. Life: Designing data elements and minimum data set (MDS) for creating the registry of patients with gestational diabetes mellitus. Med Life. 2019;12:160–7. doi: 10.25122/jml-2019-0011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hajesmaeel-Gohari S, Bahaadinbeigy K, Tajoddini S, Niakan Kalhori SR. Minimum data set development for a drug poisoning registry system. Digit Health. 2019;5:2055207619897155. doi: 10.1177/2055207619897155. doi: 10.1177/2055207619897155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Sadoughi F, Shahi M, Ahmadi M, Davaridolatabadi N. The comparison of the minimum data set for elderly health in selected countries. Acta Inform Med. 2015;23:393–7. doi: 10.5455/aim.2015.23.393-397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hsu C-C, Sandford BA. The Delphi technique: Making sense of consensus. Pract Assess Res Eval. 2007;12(1):1–8. [Google Scholar]
  • 12.Depreitere B, Citerio G, Smith M, Adelson PD, Aries M, Bleck T, et al. Cerebrovascular autoregulation monitoring in the management of adult severe traumatic brain injury: A Delphi consensus of clinicians. Neurocrit Care. 2021;34:731–8. doi: 10.1007/s12028-020-01185-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Moulaei K, Bahaadinbeigy K, Mazhari S. Designing the minimum data set of bipolar disorder: A basis for introducing the effective factors in managing, controlling, and monitoring the bipolar disorder. J Educ Health Promot. 2022;11:147–7. doi: 10.4103/jehp.jehp_971_21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Jayakumar P, Overbeek CL, Lamb S, Williams M, Funes C, Gwilym S, et al. What factors are associated with disability after upper extremity injuries. A systematic review. Clin Orthop Relat Res. 2018;476:2190–215. doi: 10.1097/CORR.0000000000000427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Datta D, Selvarajah K, Davey N. Functional outcome of patients with proximal upper limb deficiency--acquired and congenital. Clin Rehabil. 2004;18:172–7. doi: 10.1191/0269215504cr716oa. [DOI] [PubMed] [Google Scholar]
  • 16.Goldfarb CA, Shaw N, Steffen JA, Wall LB. The prevalence of congenital hand and upper extremity anomalies based upon the New York congenital malformations registry. J Pediatr Orthop. 2017;37:144–8. doi: 10.1097/BPO.0000000000000748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Bae DS, Canizares MF, Miller PE, Waters PM, Goldfarb CA. Functional impact of congenital hand differences: Early results from the congenital upper limb differences (CoULD) registry. J Hand Surg. 2018;43:321–30. doi: 10.1016/j.jhsa.2017.10.006. [DOI] [PubMed] [Google Scholar]
  • 18.Cene VH, Tosin M, Machado J, Balbinot A. Open database for accurate upper-limb intent detection using electromyography and reliable extreme learning machines. Sensors (Basel, Switzerland) 2019;19:1864. doi: 10.3390/s19081864. doi: 10.3390/s19081864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Zimmerman M, Nyman E, Dahlin LB. Occurrence of cold sensitivity in carpal tunnel syndrome and its effects on surgical outcome following open carpal tunnel release. Sci Rep. 2020;10:13471. doi: 10.1038/s41598-020-70543-8. doi: 10.1038/s41598-020-70543-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Whibley D, Martin KR, Lovell K, Jones GT. A systematic review of prognostic factors for distal upper limb pain. Br J Pain. 2015;9:241–55. doi: 10.1177/2049463715590885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Umeki N, Murata J, Higashijima M. Effects of training for finger perception on functional recovery of hemiplegic upper limbs in acute stroke patients. Occup Ther Int 2019. 2019 doi: 10.1155/2019/6508261. doi: 10.1155/2019/6508261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Stinear CM, Barber PA, Petoe M, Anwar S, Byblow WD. The PREP algorithm predicts potential for upper limb recovery after stroke. Brain. 2012;135:2527–35. doi: 10.1093/brain/aws146. [DOI] [PubMed] [Google Scholar]
  • 23.Ibikunle PO, Odole AC, Akosile CO, Ezeakunne AC. Cross-cultural adaptation and psychometric properties of the Nigerian (IGBO) version of the disabilities of the arm, shoulder and hand questionnaire (I-DASH) Hand Therapy. 2017;22:101–9. [Google Scholar]
  • 24.Hasan O, Samad A, Nawa Z, Ahmad T, Muhammad ZA, Noordin S. Preliminary radiological result after establishment of hospital-based trauma registry in level-1 trauma hospital in developing country setting, prospective cohort study. Ann Med Surg. 2018;35:95–9. doi: 10.1016/j.amsu.2018.09.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Francisco GE, Jost WH, Bavikatte G, Bandari DS, Tang SFT, Munin MC, et al. Individualized onabotulinumtoxina treatment for upper limb spasticity resulted in high clinician- and patient-reported satisfaction: Long-term observational results from the ASPIRE study. PM R. 2020;12:1120–33. doi: 10.1002/pmrj.12328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Dowrick AS, Gabbe BJ, Williamson OD. Does the presence of an upper extremity injury affect outcomes after major trauma. J Trauma. 2005;58:1175–8. doi: 10.1097/01.ta.0000169930.79684.4e. [DOI] [PubMed] [Google Scholar]
  • 27.Armijo-Olivo S, Woodhouse LJ, Steenstra IA, Gross DP. Predictive value of the DASH tool for predicting return to work of injured workers with musculoskeletal disorders of the upper extremity. Occup Environ Med. 2016;73:807–15. doi: 10.1136/oemed-2016-103791. [DOI] [PubMed] [Google Scholar]
  • 28.Braitmayer K, Dereskewitz C, Oberhauser C, Rudolf KD, Coenen M. Examination of the applicability of the disabilities of the arm, shoulder and hand (DASH) questionnaire to patients with hand injuries and diseases using rasch analysis. Patient. 2017;10:367–76. doi: 10.1007/s40271-016-0212-x. [DOI] [PubMed] [Google Scholar]
  • 29.Giang GM. Epidemiology of work-related upper extremity disorders: Understanding prevalence and outcomes to impact provider performances using a practice management reporting tool. Clin Occup Environ Med. 2006;5:267–83. doi: 10.1016/j.coem.2005.12.002. vi. [DOI] [PubMed] [Google Scholar]
  • 30.Ro JS, Leigh JH, Jeon I, Bang MS. Trends in burden of work-related upper limb amputation in South Korea, 2004-2013: A nationwide retrospective cohort study. BMJ Open. 2019;9:e032793. doi: 10.1136/bmjopen-2019-032793. doi: 10.1136/bmjopen-2019-032793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Marrie RA, Cutter GR, Tyry T, Cofield SS, Fox R, Salter A. Upper limb impairment is associated with use of assistive devices and unemployment in multiple sclerosis. Mult Scler Relat Disord. 2017;13:87–92. doi: 10.1016/j.msard.2017.02.013. [DOI] [PubMed] [Google Scholar]
  • 32.Gironda RJ, Clark ME, Neugaard B, Nelson A. Upper limb pain in a national sample of veterans with paraplegia. J Spinal Cord Med. 2004;27:120–7. doi: 10.1080/10790268.2004.11753742. [DOI] [PubMed] [Google Scholar]
  • 33.Tang K, Beaton DE, Hogg-Johnson S, Cote P, Loisel P, Amick BC. Does the upper-limb work instability scale predict transitions out of work among injured workers. Arch Phys Med Rehabil. 2015;96:1658–65. doi: 10.1016/j.apmr.2015.04.022. [DOI] [PubMed] [Google Scholar]
  • 34.Waljee JF, Carlozzi N, Franzblau LE, Zhong L, Chung KC. Applying the patient-reported outcomes measurement information system to assess upper extremity function among children with congenital hand differences. Plastic Reconstr Surg. 2015;136:200e–7e. doi: 10.1097/PRS.0000000000001444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Conroy C, Schwartz A, Hoyt DB, Brent Eastman A, Pacyna S, Holbrook TL, et al. Upper extremity fracture patterns following motor vehicle crashes differ for drivers and passengers. Injury. 2007;38:350–7. doi: 10.1016/j.injury.2006.03.017. [DOI] [PubMed] [Google Scholar]
  • 36.Spreeuwers D, de Boer A, Verbeek J, van Beurden MM, de Wilde NS, Braam I, et al. Work-related upper extremity disorders: One-year follow-up in an occupational diseases registry. Int Arch Occup Environ Health. 2011;84:789–96. doi: 10.1007/s00420-011-0611-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Kovacic J, Bergfeld J. Return to play issues in upper extremity injuries. Clin J Sport Med. 2005;15:448–52. doi: 10.1097/01.jsm.0000188208.00727.0b. [DOI] [PubMed] [Google Scholar]
  • 38.Garbellini S, Robert Y, Randall M, Elliott C, Imms C. Rationale for prescription, and effectiveness of, upper limb orthotic intervention for children with cerebral palsy: A systematic review. Disabil Rehabil. 2018;40:1361–71. doi: 10.1080/09638288.2017.1297498. [DOI] [PubMed] [Google Scholar]
  • 39.vanderSluis CK, Kucey DS, Brenneman FD, Hunter GA, Maggisano R, tenDuis HJ. Long-term outcomes after upper limb arterial injuries. Can J Surg. 1997;40:265–70. [PMC free article] [PubMed] [Google Scholar]
  • 40.Tennent DJ, Wenke JC, Rivera JC, Krueger CA. Characterisation and outcomes of upper extremity amputations. Injury. 2014;45:965–9. doi: 10.1016/j.injury.2014.02.009. [DOI] [PubMed] [Google Scholar]
  • 41.Lutfy J, Pietak A, Mendenhall SD, Neumeister MW. Clinical application of mathematical long bone ratios to calculate appropriate donor limb lengths in bilateral upper limb transplantation. Hand (New York, NY) 2019;14:523–9. doi: 10.1177/1558944717753672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Liang HW, Chen SY, Hsu JH, Chang CW. Work-related upper limb amputations in Taiwan, 1999-2001. Am J Indus Med. 2004;46:649–55. doi: 10.1002/ajim.20098. [DOI] [PubMed] [Google Scholar]
  • 43.Dragas M, Davidovic L, Kostic D, Markovic M, Pejkic S, Ille T, et al. Upper extremity arterial injuries: Factors influencing treatment outcome. Injury. 2009;40:815–9. doi: 10.1016/j.injury.2008.08.012. [DOI] [PubMed] [Google Scholar]
  • 44.Alentorn-Geli E, Wanderman NR, Assenmacher AT, Elhassan BT, Sanchez-Sotelo J, Cofield RH, et al. Reverse shoulder arthroplasty in patients with amputation or paralysis of the contralateral upper extremity (One-Arm Patients) PM R. 2017;9:1006–12. doi: 10.1016/j.pmrj.2017.03.006. [DOI] [PubMed] [Google Scholar]
  • 45.Andersen LV, Mortensen LS, Lindholt JS, Faergeman O, Henneberg EW, Frost L. Upper-limb thrombo-embolectomy: National cohort study in Denmark. Eur J Vasc Endovasc Surg. 2010;40:628–34. doi: 10.1016/j.ejvs.2010.06.009. [DOI] [PubMed] [Google Scholar]
  • 46.Yelvington ML, Godleski M, Lee AF, Goverman J, Herndon DN, Suman OE, et al. A comparison of contracture severity at acute discharge in patients with and without heterotopic ossification: A burn model system national database study. J Burn Care Res. 2019;40:349–54. doi: 10.1093/jbcr/irz031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Tyson SF, Kent RM. WITHDRAWN: Orthotic devices after stroke and other non-progressive brain lesions. Cochrane Database Syst Rev. 2009;2009:Cd003694. doi: 10.1002/14651858.CD003694.pub3. doi: 10.1002/14651858.CD003694.pub3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Lehman LA, Sindhu BS, Johnson J, Velozo CA. Creating a clinically useful data collection form for the DASH questionnaire. Am J Occup Ther. 2011;65:45–54. doi: 10.5014/ajot.2011.09218. [DOI] [PubMed] [Google Scholar]
  • 49.Hou WH, Chi CC, Lo HL, Kuo KN, Chuang HY. Vocational rehabilitation for enhancing return-to-work in workers with traumatic upper limb injuries. Cochrane Database Syst Rev. 2013:Cd010002. doi: 10.1002/14651858.CD010002.pub2. doi: 10.1002/14651858.CD010002.pub3. [DOI] [PubMed] [Google Scholar]
  • 50.Farzad M, Layeghi F, Asgari A, Hosseini SA, Rassafiani M. Evaluation of non diseased specified outcome measures in hand injuries to assess activity and participation based on ICF content. J Hand Microsurg. 2014;6:27–34. doi: 10.1007/s12593-013-0109-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Curtin CM, Gater DR, Chung KC. Upper extremity reconstruction in the tetraplegic population, a national epidemiologic study. J Hand Surg. 2005;30:94–9. doi: 10.1016/j.jhsa.2004.10.007. [DOI] [PubMed] [Google Scholar]
  • 52.Corrêa A. G. D, Kintschner N. R, Blascovi-Assis S. M. System of Upper Limb Motor Rehabilitation Training Using Leap Motion and Gear VR in Sessions of Home Game Therapy. 2019 IEEE Symposium on Computers andCommunications (ISCC) (pp. 1097-1102). IEEE. 2019 June [Google Scholar]
  • 53.Whibley D, MacDonald R, Macfarlane GJ, Jones GT. Constructs of health belief and disabling distal upper limb pain. Scand J Pain. 2016;13:91–7. doi: 10.1016/j.sjpain.2016.07.003. [DOI] [PubMed] [Google Scholar]
  • 54.Roy JS, MacDermid JC, Woodhouse LJ. Measuring shoulder function: A systematic review of four questionnaires. Arthritis Rheum. 2009;61:623–32. doi: 10.1002/art.24396. [DOI] [PubMed] [Google Scholar]
  • 55.Luke C, Dodd KJ, Brock K. Outcomes of the Bobath concept on upper limb recovery following stroke. Clin Rehabil. 2004;18:888–98. doi: 10.1191/0269215504cr793oa. [DOI] [PubMed] [Google Scholar]
  • 56.Kuhn AW, Kuhn JE. Upper extremity pain and overuse injuries in fly-fishing: A North American cross-sectional survey and implications for injury prevention. Orthop J Sports Med. 2020;8:2325967120959303. doi: 10.1177/2325967120959303. doi: 10.1177/2325967120959303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Arab Alkabeya H, Hughes AM, Adams J. Factors associated with hand and upper arm functional disability in people with rheumatoid arthritis: A systematic review. Arthritis Care Res. 2019;71:1473–81. doi: 10.1002/acr.23784. [DOI] [PubMed] [Google Scholar]
  • 58.Ager AL, Roy JS, Gamachet F, Hebert LJ. The effectiveness of an upper extremity neuromuscular training program on the shoulder function of military members with a rotator cuff tendinopathy: A pilot randomized controlled trial. Mil Med. 2019;184:E385–93. doi: 10.1093/milmed/usy294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Vansteenkiste S, Reneman MF, van der Eerden PJM, Soer R, Dijkstra PU, van der Sluis CK. Upper limb functional capacity of working patients with osteoarthritis of the hands: A cross-sectional study. J Hand Ther. 2017;30:507–15. doi: 10.1016/j.jht.2017.01.003. [DOI] [PubMed] [Google Scholar]
  • 60.d’Almeida KW, Godard C, Leclerc A, Lahon G. Sickness absence for upper limb disorders in a French company. Occup Med. 2008;58:506–8. doi: 10.1093/occmed/kqn084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Ejnisman B, Andreoli CV, Soares BG, Fallopa F, Peccin MS, Abdalla RJ, et al. Interventions for tears of the rotator cuff in adults. Cochrane Database Syst Rev. 2004:Cd002758. doi: 10.1002/14651858.CD002758.pub2. doi: 10.1002/14651858.CD002758.pub2. [DOI] [PubMed] [Google Scholar]
  • 62.Feys P, Duportail M, Kos D, Van Asch P, Ketelaer P. Validity of the TEMPA for the measurement of upper limb function in multiple sclerosis. Clin Rehabil. 2002;16:166–73. doi: 10.1191/0269215502cr471oa. [DOI] [PubMed] [Google Scholar]
  • 63.Wallen M, Stewart K. Upper limb function in everyday life of children with cerebral palsy: Description and review of parent report measures. Disabil Rehabil. 2015;37:1353–61. doi: 10.3109/09638288.2014.963704. [DOI] [PubMed] [Google Scholar]
  • 64.Parker J, Mountain G, Hammerton J. A review of the evidence underpinning the use of visual and auditory feedback for computer technology in post-stroke upper-limb rehabilitation. Disabil Rehabil Assist Technol. 2011;6:465–72. doi: 10.3109/17483107.2011.556209. [DOI] [PubMed] [Google Scholar]
  • 65.Navalkele D, Vahidy F, Kendrick S, Traylor A, Haydel M, Drury S, et al. Vision, aphasia, neglect assessment for large vessel occlusion stroke. J Stroke Cerebrovasc Dis. 2020;29:104478. doi: 10.1016/j.jstrokecerebrovasdis.2019.104478. doi: 10.1016/j.jstrokecerebrovasdis. 2019.104478. [DOI] [PubMed] [Google Scholar]
  • 66.Gupta A, Singh A, Verma V, Mondal AK, Gupta MK. Developments and clinical evaluations of robotic exoskeleton technology for human upper-limb rehabilitation. Adv Robot. 2020;34:1023–40. [Google Scholar]
  • 67.Chaeibakhsh S, Phillips E, Buchanan A, Wade E. Upper Extremity Post-stroke motion quality estimation with decision trees and bagging forests. In: Patton J, Barbieri R, Ji J, Jabbari E, Dokos S, Mukkamala R, et al., editors. 2016 38th Annual International Conference of the Ieee Engineering in Medicine and Biology Society. 2016. pp. 4585–4588. [DOI] [PubMed] [Google Scholar]
  • 68.Burgess A, Boyd RN, Ziviani J, Sakzewski L. A systematic review of upper limb activity measures for 5- to 18-year-old children with bilateral cerebral palsy. Aust Occup Ther J. 2019;66:552–67. doi: 10.1111/1440-1630.12600. [DOI] [PubMed] [Google Scholar]
  • 69.Thielen CC, Marino RJ, Duff S, Kaplan G, Mulcahey MJ. Activity-based rehabilitation interventions of the neurologically impaired upper extremity. Description of a scoping review protocol. Top Spinal Cord Injury Rehabil. 2018;24:288–94. doi: 10.1310/sci2403-288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Jia S, Liu Y, Shen L, Liang X, Xu X, Wei Y. Botulinum toxin type a for upper limb spasticity in poststroke patients: A meta-analysis of randomized controlled trials. J Stroke Cerebrovasc Dis. 2020;29:104682. doi: 10.1016/j.jstrokecerebrovasdis.2020.104682. doi: 10.1016/j.jstrokecerebrovasdis. 2020.104682. [DOI] [PubMed] [Google Scholar]
  • 71.McConnell K, Johnston L, Kerr C. Upper limb function and deformity in cerebral palsy: A review of classification systems. Dev Med Child Neurol. 2011;53:799–805. doi: 10.1111/j.1469-8749.2011.03953.x. [DOI] [PubMed] [Google Scholar]
  • 72.Dekkers K, Rameckers EAA, Smeets R, Janssen-Potten YJM. Upper extremity strength measurement for children with cerebral palsy: A systematic review of available instruments. Phys Ther. 2014;94:609–22. doi: 10.2522/ptj.20130166. [DOI] [PubMed] [Google Scholar]
  • 73.Pransky G, Benjamin K, Himmelstein J, Mundt K, Morgan W, Feuerstein M, et al. Work-related upper-extremity disorders: Prospective evaluation of clinical and functional outcomes. J Occup Environ Med. 1999;41:884–92. doi: 10.1097/00043764-199910000-00009. [DOI] [PubMed] [Google Scholar]
  • 74.Assouline U, Feuvrier D, Lepage D, Tropet Y, Obert L, Pauchot J. Functional assessment and quality of life in patients following replantation of the distal half of the forearm (except fingers): A review of 11 cases. Hand Surg Rehabil. 2017;36:261–7. doi: 10.1016/j.hansur.2017.05.002. [DOI] [PubMed] [Google Scholar]
  • 75.Huang GD, Feuerstein M, Berkowitz SM, Peck CA. Occupational upper-extremity-related disability: Demographic, physical, and psychosocial factors. Mil Med. 1998;163:552–8. [PubMed] [Google Scholar]
  • 76.Huang GD, Feuerstein M, Arroyo F. Back and upper extremity disorders among enlisted US marines: Burden and individual risk factors. Mil Med. 2001;166:1007–17. [PubMed] [Google Scholar]
  • 77.Biering-Sørensen F, Bryden A, Curt A, Friden J, Harvey LA, Mulcahey MJ, et al. International spinal cord injury upper extremity basic data set. Spinal Cord. 2014;52:652–7. doi: 10.1038/sc.2014.87. [DOI] [PubMed] [Google Scholar]
  • 78.DeVivo M, Biering-Sørensen F, Charlifue S, Noonan V, Post M, Stripling T, et al. International spinal cord injury core data set. Spinal Cord. 2006;44:535–40. doi: 10.1038/sj.sc.3101958. [DOI] [PubMed] [Google Scholar]
  • 79.Carrel M, Rennie S. Demographic and health surveillance: Longitudinal ethical considerations. Bull World Health Organ. 2008;86:612–6. doi: 10.2471/BLT.08.051037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Richesson R, Vehik K. Patient registries: Utility, validity and inference. Adv Exp Med Biol. 2010;686:87–104. doi: 10.1007/978-90-481-9485-8_6. [DOI] [PubMed] [Google Scholar]
  • 81.Lucyk K, Tang K, Quan H. Barriers to data quality resulting from the process of coding health information to administrative data: A qualitative study. BMC Health Serv Res. 2017;17:1–10. doi: 10.1186/s12913-017-2697-y. doi: 10.1186/s12913-017-2697-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Kazemi-Arpanahi H, Vasheghani-Farahani A, Baradaran A, Ghazisaeedi M, Mohammadzadeh N, Bostan H. Development of a minimum data set for cardiac electrophysiology study ablation. J Educ Health Promot. 2019;8:1–7. doi: 10.4103/jehp.jehp_232_18. doi: 10.4103/jehp.jehp_232_18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Meystre SM, Lovis C, Bürkle T, Tognola G, Budrionis A, Lehmann CU. Clinical data reuse or secondary use: Current status and potential future progress. Yearb Med Inform. 2017;26:38–52. doi: 10.15265/IY-2017-007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Fahimi F. Implementation of a clinical pharmacy education program in a teaching hospital: Resident oriented documentation and intervention. Iran J Pharm Res. 2010;9:297–302. [PMC free article] [PubMed] [Google Scholar]
  • 85.Hughes A-M, Bouças SB, Burridge JH, Alt Murphy M, Buurke J, Feys P, et al. Evaluation of upper extremity neurorehabilitation using technology: A European Delphi consensus study within the EU COST action network on robotics for neurorehabilitation. J Neuroeng Rehabil. 2016;13:86. doi: 10.1186/s12984-016-0192-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Biering-Sørensen F, Burns A, Curt A, Harvey L, Jane Mulcahey M, Nance P, et al. International spinal cord injury musculoskeletal basic data set. Spinal Cord. 2012;50:797–802. doi: 10.1038/sc.2012.102. [DOI] [PubMed] [Google Scholar]
  • 87.Widerström-Noga E, Biering-Sørensen F, Bryce T, Cardenas DD, Finnerup NB, Jensen MP, et al. The international spinal cord injury pain basic data set. Spinal Cord. 2008;46:818–23. doi: 10.1038/sc.2008.64. [DOI] [PubMed] [Google Scholar]
  • 88.Davidson J. A comparison of upper limb amputees and patients with upper limb injuries using the disability of the arm, shoulder and hand (DASH) Disabil Rehabil. 2004;26:917–23. doi: 10.1080/09638280410001708940. [DOI] [PubMed] [Google Scholar]
  • 89.Lyle RC. A performance test for assessment of upper limb function in physical rehabilitation treatment and research. Int J Rehabil Res. 1981;4:483–92. doi: 10.1097/00004356-198112000-00001. [DOI] [PubMed] [Google Scholar]
  • 90.Naghdi S, Ansari NN, Mansouri K, Hasson S. A neurophysiological and clinical study of Brunnstrom recovery stages in the upper limb following stroke. Brain Inj. 2010;24:1372–8. doi: 10.3109/02699052.2010.506860. [DOI] [PubMed] [Google Scholar]
  • 91.Garbellini S, Randall M, Steele M, Elliott C, Imms C. Prescribing upper limb orthoses for children with cerebral palsy: A Q methodology study of occupational therapists’ decision making. Disabil Rehabil. 2020;42:2600–10. doi: 10.1080/09638288.2019.1573931. [DOI] [PubMed] [Google Scholar]
  • 92.Russo RN, Atkins R, Haan E, Crotty M. Upper limb orthoses and assistive technology utilization in children with hemiplegic cerebral palsy recruited from a population register. Dev Neurorehabil. 2009;12:92–9. doi: 10.1080/17518420902783223. [DOI] [PubMed] [Google Scholar]
  • 93.Olvey EL, Armstrong EP, Grizzle AJ. Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: A systematic review. Clin Ther. 2010;32:2282–303. doi: 10.1016/j.clinthera.2011.01.005. [DOI] [PubMed] [Google Scholar]
  • 94.Tacata IS. Functional outcome after treatment of TB of upper limbs. BMC Proceedings: 2015, BioMed Central. 2015;9(3):1–1. [Google Scholar]
  • 95.Foley N, Pereira S, Salter K, Fernandez MM, Speechley M, Sequeira K, et al. Treatment with botulinum toxin improves upper-extremity function post stroke: A systematic review and meta-analysis. Arch Phys Med Rehabil. 2013;94:977–89. doi: 10.1016/j.apmr.2012.12.006. [DOI] [PubMed] [Google Scholar]
  • 96.Farag SM, Mohammed MO, El-Sobky TA, ElKadery NA, ElZohiery AK. Botulinum toxin A injection in treatment of upper limb spasticity in children with cerebral palsy: A systematic review of randomized controlled trials. JBJS Rev. 2020;8:e0119. doi: 10.2106/JBJS.RVW.19.00119. doi: 10.2106/JBJS.RVW.19.00119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Basmajian J, Gowland C, Brandstater M, Swanson L, Trotter J. EMG feedback treatment of upper limb in hemiplegic stroke patients: A pilot study. Arch Phys Med Rehabil. 1982;63:613–6. [PubMed] [Google Scholar]
  • 98.Stewart C, Subbarayan S, Paton P, Gemmell E, Abraha I, Myint PK, et al. Non-pharmacological interventions for the improvement of post-stroke activities of daily living and disability amongst older stroke survivors: A systematic review. PLoS One. 2018;13:e0204774. doi: 10.1371/journal.pone.0204774. doi: 10.1371/journal.pone.0204774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Brandeis GH, Baumann MM, Hossain M, Morris JN, Resnick NM. The prevalence of potentially remediable urinary incontinence in frail older people: A study using the minimum data set. J Am Geriatr Soc. 1997;45:179–84. doi: 10.1111/j.1532-5415.1997.tb04504.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Education and Health Promotion are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES